Literature DB >> 9289260

In vitro sensitivity of Plasmodium falciparum to anti-folinic agents (trimethoprim, pyrimethamine, cycloguanil): a study of 29 African strains.

L K Basco1, J Le Bras.   

Abstract

The in vitro drug sensitivity of three dihydrofolate reductase inhibitors (pyrimethamine, cycloguanil, trimethoprim) was determined against 29 strains and isolates of Plasmodium falciparum by an isotopic semi-microtest. Trimethoprim is less active than pyrimethamine or cycloguanil and its activity is correlated with that of two other inhibitors, suggesting cross-resistance in vitro among the dihydrofolate reductase inhibitors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9289260

Source DB:  PubMed          Journal:  Bull Soc Pathol Exot        ISSN: 0037-9085


  3 in total

1.  Evolution of resistance to sulfadoxine-pyrimethamine in Plasmodium falciparum.

Authors:  Michelle L Gatton; Laura B Martin; Qin Cheng
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

2.  In vitro activity of antifolate and polymorphism in dihydrofolate reductase of Plasmodium falciparum isolates from the Kenyan coast: emergence of parasites with Ile-164-Leu mutation.

Authors:  Steven M Kiara; John Okombo; Victor Masseno; Leah Mwai; Isabella Ochola; Steffen Borrmann; Alexis Nzila
Journal:  Antimicrob Agents Chemother       Date:  2009-06-15       Impact factor: 5.191

3.  Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use.

Authors:  Nitchakarn Noranate; Rémy Durand; Adama Tall; Laurence Marrama; André Spiegel; Cheikh Sokhna; Bruno Pradines; Sandrine Cojean; Micheline Guillotte; Emmanuel Bischoff; Marie-Thérèse Ekala; Christiane Bouchier; Thierry Fandeur; Frédéric Ariey; Jintana Patarapotikul; Jacques Le Bras; Jean François Trape; Christophe Rogier; Odile Mercereau-Puijalon
Journal:  PLoS One       Date:  2007-01-03       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.